ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $7,000 | +250.0% | 4,940 | +183.9% | 0.00% | +300.0% |
Q4 2016 | $2,000 | -33.3% | 1,740 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $3,000 | 0.0% | 1,740 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $3,000 | 0.0% | 1,740 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $3,000 | 0.0% | 1,740 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $3,000 | 0.0% | 1,740 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $3,000 | -62.5% | 1,740 | 0.0% | 0.00% | -66.7% |
Q2 2015 | $8,000 | 0.0% | 1,740 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $8,000 | +33.3% | 1,740 | 0.0% | 0.01% | +50.0% |
Q4 2014 | $6,000 | -14.3% | 1,740 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $7,000 | -30.0% | 1,740 | 0.0% | 0.01% | -33.3% |
Q2 2014 | $10,000 | -9.1% | 1,740 | 0.0% | 0.01% | -25.0% |
Q1 2014 | $11,000 | +10.0% | 1,740 | 0.0% | 0.01% | +100.0% |
Q4 2013 | $10,000 | +11.1% | 1,740 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $9,000 | -30.8% | 1,740 | 0.0% | 0.01% | -40.0% |
Q2 2013 | $13,000 | – | 1,740 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |